Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Diabetes
•
Endocrinology
•
Male and Female Reproductive Disorders
Do you regularly counsel younger women of childbearing age about the impact of Tirzepatide on oral hormonal contraception?
https://pubmed.ncbi.nlm.nih.gov/37940101/
Related Questions
Do you recommend adding low-dose Aspirin for primary prevention in patients with Type 2 Diabetes on Eliquis for another indication?
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Do you recommend the use of GLP 1 R agonist therapy for obese women with PCOS who are actively trying to conceive?
How do you evaluate/treat a patient with minimal papillary thyroid cancer foci in ovarian mature teratoma tissue (after an oophorectomy) that does not meet criteria for struma ovarii diagnosis?
Do you recommend the use of GLP1 R agonist therapy in patients with T1DM for weight loss?
How do you approach managing patients with diabetic kidney disease and proteinuria who develop hypoglycemia after initiation of a SGLT2 inhibitor?
Do 5HT4 agonists such as Metoclopramide actually lead to improvement in symptoms for patients with diabetes related gastroparesis?
How do you adjust your HbA1c goal for managing diabetes in elderly patients with multiple chronic illnesses but no limitations in performing self-care tasks?
Can clomiphene therapy cause low libido while increasing the testosterone level in men with low testosterone?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?